Mode
Text Size
Log in / Sign up

ERAS protocols for scoliosis surgery are planned for evaluation in a systematic review meta-analysisERAS protocols may shorten hospital stay for scoliosis surgery

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that no results are available as this is a protocol for a systematic review and meta-analysis.

This publication is a protocol for a systematic review and meta-analysis focused on the impact of Enhanced Recovery After Surgery (ERAS) protocols compared to conventional care for patients undergoing scoliosis correction surgery. The planned analysis aims to evaluate primary outcomes including length of hospital stay, as well as secondary outcomes such as postoperative complications, pain intensity, opioid consumption, time to ambulation, readmission rates, patient satisfaction, healthcare costs, and adverse events.

Because this is a protocol only, no data results are currently available. No effect sizes, p-values, or confidence intervals have been established. The study design aims to identify evidence that could inform clinical practice and support the development of future guidelines for scoliosis surgery management.

Clinical application of these findings is not yet possible as the systematic review has not been conducted. The protocol highlights specific gaps in current research regarding ERAS implementation in this surgical population.

How this fits prior evidence

This protocol addresses a gap in evidence regarding the efficacy of Enhanced Recovery After Surgery (ERAS) protocols for scoliosis surgery. While previous coverage noted a shift toward bone quality assessment and risk stratification in scoliosis management, this planned meta-analysis focuses on postoperative recovery metrics like length of stay and pain intensity.

If you or someone you love is facing scoliosis correction surgery, you know recovery can be tough. Now researchers are planning to look at whether a set of care steps called Enhanced Recovery After Surgery (ERAS) can help people get out of the hospital faster and feel better sooner.

This is a protocol for a systematic review and meta-analysis. That means the researchers have laid out their plan to gather and combine data from multiple studies. They want to see if ERAS protocols beat conventional care for scoliosis surgery. The main goal is to shorten hospital stays. They also plan to check for fewer complications, less pain, lower opioid use, quicker walking, fewer readmissions, higher satisfaction, and lower costs.

But here's the catch: this is just the plan. No results are available yet. The review hasn't been done. So we don't know if ERAS actually works better. The researchers will need to find enough good studies to analyze. Until then, it's an idea worth watching, but not something to act on.

If you're considering scoliosis surgery, talk to your surgeon about recovery options. This review might eventually give clearer answers, but for now, it's a roadmap for future research.

What this means for you:
A planned review will test if ERAS protocols improve recovery after scoliosis surgery.

Common questions

What is ERAS for scoliosis surgery?

ERAS stands for Enhanced Recovery After Surgery. It's a set of care steps designed to help patients recover faster. For scoliosis surgery, it might include things like better pain control, early movement, and nutrition. This review plans to compare ERAS to conventional care to see if it really helps.

Does this review show that ERAS works?

No. This is only a protocol, which is a plan for a future review. No results are available yet. The researchers have not analyzed any data. So we don't know if ERAS is better than conventional care for scoliosis surgery. We have to wait for the actual review to be completed.

Who is this review for?

This review is for patients undergoing scoliosis correction surgery and their doctors. The findings are expected to inform clinical practice and help develop guidelines. But since it's just a protocol, it doesn't provide any answers yet. Patients should talk to their surgeon about recovery options.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedJul 2026
View Original Abstract ↓
Scoliosis correction surgery is associated with significant perioperative morbidity and prolonged recovery. Enhanced Recovery After Surgery (ERAS) protocols, which employ evidence-based, multimodal perioperative care, have been increasingly used in spinal surgery to improve patient outcomes. However, their efficacy and safety in scoliosis correction surgery remain unclear. This protocol describes a systematic review and meta-analysis following PRISMA-P guidelines. We will systematically search electronic databases from inception to January 2026 for randomized controlled trials and observational studies comparing ERAS protocols with conventional care in patients undergoing scoliosis correction surgery. The primary outcome will be length of hospital stay. Secondary outcomes will include postoperative complications, pain intensity, opioid consumption, time to ambulation, readmission rates, patient satisfaction, healthcare costs, and adverse events. Two independent reviewers will screen studies, extract data, and assess methodological quality using the Cochrane Risk of Bias tool version 2 for randomized trials and the Risk of Bias in Non-randomized Studies - of Interventions tool for non-randomized studies. Meta-analysis will be performed using Review Manager version 5.4 and Stata version 17 when feasible. The certainty of evidence will be assessed using the GRADE approach. This systematic review and meta-analysis will synthesize current evidence on the effectiveness and safety of ERAS protocols in scoliosis correction surgery. The findings are expected to inform clinical practice, support guideline development, and highlight gaps for future research. Results will be disseminated via peer-reviewed publication and scientific meetings.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.